In the news
Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel Chemically Diverse Macrocycles
MORE NEWS
5
08/30/2022
Fierce Biotech: Arch builds bridge to new class of medicines, leading $50M investment in the AI-enabled Vilyas
6
08/29/2022
Vilya launches to design a new transformational class of medicines that precisely target disease biology
8
08/29/2022
UW Institute for Protein Design: Design of membrane-traversing peptides leads to new spinout
9
08/29/2022
David Baker’s lab and ARCH sprout Lord of the Rings-inspired macrocycle biotech
10
08/29/2022
Timmerman Report: Arch bets $50M on Vilya, Baker Lab Spinout to Make Targeted, Oral Peptide Drugs
11
